Use of ambulatory electrocardiography for the detection of paroxysmal atrial fibrillation in patients with stroke

Canadian Journal of Neurological Sciences

Volumn 27, Issue 1, 2000, Pages 25-31

  Bell, Chaim ^a,d   Kapral, Moira ^b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c Institute for Clinical and Evaluative Sciences

^d Can Task Force on Prev Health Care   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

AMBULATORY MONITORING; ARTICLE; BLEEDING; CANADA; CLINICAL TRIAL; ELECTROCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; META ANALYSIS; PRIORITY JOURNAL; RECURRENCE RISK; STROKE;

EID: 0033997346     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0317167100051933     Document Type: Article

References (80)

1. Statistics Canada, Health Canada, Heart and Stroke Foundation of Canada, editors. Heart Disease and Stroke in Canada 1997.
2. Statistics Canada. Causes of death, 1993. Cat. 84-208 (Annual).
3. Bonita R. Epidemiology of stroke. Lancet 1992;339:342-347.
4. Moore R, Mao Y, Zhang J, Clake K. Economic burden of illness in Canada, 1993. Catalogue No H21-136/1993E, Canadian Public Health Association, 1997 (http://www.hwc.ca/hpb/lcdc/publicat/ burden/index .html)
5. Cerebral Embolism Task Force. Cardiogenic brain embolism: the second report of the Cerebral Embolism Task Force. Arch Neurol 1989;46:727-743.
6. Sherman DG, Dyken ML, Fisher M, et al. Cerebral embolism. Chest 1986;89 (suppl):82S-98S.
7. Sandercock P, Bamford J, Dennis M, et al. Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project). Br Med J 1992;305:1460-5.
8. Broderick JP, Phillips SJ, O'Fallon M, Frye RL, Whisnant JP. Relationship of cardiac disease to stroke occurrence, recurrence, and mortality. Stroke 1992;23:1250-1256.
9. Phillips SJ, Whisnant JP, O'Fallon WM, Frye RL. Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. Mayo Clin Proc 1990;65:344-359.
10. Cerebral Embolism Task Force. Cardiogenic brain embolism. Arch Neurol 1986;43:71-84.
11. Bharucha NE, Wolf PA, Kannel WB, et al. Epidemiological study of cerebral embolism: the Framingham Study, abstracted. Ann Neurol 1981;10:105.
12. Sherman DG, Goldman L, Whiting RB, et al. Thromboembolism in patients with atrial fibrillation. Arch Neurol 1984;708-710.
13. Lin H-J, Wolf PA, Benjamin El, et al. Newly diagnosed atrial fibrillation and acute stroke: the Framingham Study. Stroke 1995;26:1527-1530.
14. Selzer A. Atrial fibrillation revisited. N Engl J Med 1982;306:1044-1045.
15. Bougousslavsky J, Van Meile G, Regli F. The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke 1988;19:1083-1092.
16. Woolf SH, Battista RN, Anderson GM, Logan AG, Wang E and other members of the Canadian Task Force on the Periodic Health Examination. Assessing the clinical effectiveness of preventive manoeuvers: analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. J Clin Epidemiol 1990; 43(9): 891-905.
17. The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. Ann Int Med 1992; 116:1-5.
18. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Arch Intern Med 1994;154:1449-1457.
19. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. Patients with non-valvular atrial fibrillation at low risk of stroke during treatment with aspirin. JAMA 1998;279:1273-1277.
20. Green CJ, Hadom DC, Bassett K, Kazanjian A. Anticoagulation in chronic non-valvular atrial fibrillation: a critical appraisal and meta-analysis. Can J Cardiol 1997;13:811-815.
21. Ezekowitz MD, Bridgers SL, James KE, et al. Warfarin in the prevention of stroke associated with non-rheumatic atrial fibrillation. N Engl J Med 1992;327:1406-1412.
22. EAFT Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischemie attack or minor stroke. Lancet 1993;342:1255-1262.
23. Gajewski J, Singer RB. Mortality in an insured population with atrial fibrillation. JAMA 1981;245:1540-1544.
24. , 24. Kannel WB, Abbot RD, Savage DD, McNamara PM. Coronary heart disease and atrial fibrillation: the Framinaham Study. Am Heart J 1983;106:389-396.
25. Treseder AS.Sastry BSD,Thomas TPL, et al. Atrial fibrillation and stroke in elderly hospitalized patients. Age and Ageing 1986;15:89-92.
26. Takahashi N, Seki A, Imataka K, Fujii J. Clinical features of paroxysmal atrial fibrillation. An observation of 94 patients. Jpn Heart J 1981;22:143-149.
27. Shimomura K, Ohe T, Uehara S et al. Significance of atrial fibrillation as a precursor of embolism. Am J Cardiol - 1989;63:1405-1407.
28. Wiener I, Hafner R, Nicolai M, Lyons H. Clinical and echocardiographic correlates of systemic embolization in nonrheumatic atrial fibrillation. Am J Cardiol 1987;59:177.
29. Roy D, Marchand E, Gagne P, et al. Usefulness of anticoagulant therapy in the prevention of embolie complications of atrial fibrillation. Am Heart J 1986;112:1039-1043.
30. Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study: final results. Circulation 1991;84:527-539.
31. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. Effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atrial fibrillation. N Engl J Med 1990;323:1506-1511.
32. Laupacis A, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation. Chest 1995;108 (suppl):352-359S.
33. Petersen P and Godtfredsen J. Embolie complications in paroxysmal atrial fibrillation. Stroke 1986;17:622-626.
34. Auguste H, Fortin BA, Isner JM. Should patients with paroxysmal atrial fibrillation receive prophylactic anticoagulation? J Am Coll Cardiol 1983;1:704.
35. Corbalan R, Arriagada D, Braun S, et al. Risk factors for systemic embolism in patients with paroxysmal atrial fibrillation. Am Heart J 1992;124:149-153.
36. Lip GYH. Does paroxysmal atrial fibrillation confer a paroxysmal thromboembolic risk? Lancet 1997;349:1565-1566.
37. Lip GYH, Lowe GDO. ABC of atrial fibrillation. Antithrombotic therapy for atrial fibrillation. Br Med J 1996;312:45-49.
38. Goldstein LB, Bonito AJ, Matchar DB, et al. US national survey of physician practices for the secondary and tertiary prevention of ischemie stroke: design, service availability, and common practices. Stroke 1995;26:1607-1615.
39. British Columbia Medical Association Guide to Fees. Page 103. April 1995.
40. Manitoba Health Services Insurance Plan - Physician's manual. Page H-I.April 1995.
41. Medical Specialists' Manual Health Insurance Plan. Page C-10. December 1996.
42. Alberta Health Care Insurance Plan Schedule of Medical Discipline Benefits. Page 10. January 1997.
43. Ontario Ministry of Health Schedule of Benefits. Page J-6. February 1998.
44. Knoebel SB, et al. American College of Cardiology/American Heart Association. Guidelines for ambulatory electrocardiography. JACC 1989;13:249-258.
45. Pratt CM, Eaton T, Francis M, Pacifico A. Ambulatory electrocardiographie recordings: the Holler monitor. Curr Probl Cardiol 1988;13:521-586.
46. DiMarco JP, Philbrick JT. Use of ambulatory electrocardiographic (Holier) monitoring. Ann Intern Med 1990;! 13:53-68.
47. Zimelbaum PJ and Josephson ME. The evolving role of ambulatory arrhythmia monitoring in general praclice. Ann Inlern Med 1999;130:848-856.
48. Murakami Y, Okamolo M, Nakayama R. Atrial late potenlial by P wave-triggered signal-averaged electrocardiogram and paroxysmal alrial fibrillalion. Nippon Rinsho 1995:53:489-495.
49. Stafford PJ, Cooper J, Fothergill J, et al. Reproducibility of the signal-averaged P wave: time and frequency domain analysis. Heart 1997;77:412-416.
50. Michelucci A, Padeletti L, Chelucci A, et al. Influence of age, lead axis, frequency of arrhythmic episodes, and atrial dimensions on P wave iriggered SAECG in palients with lone paroxysmal alrial fibrillalion. Pacing Clin Eleclrophysiol 1996;19:758-767.
51. Yamaguchi I, Kuga K, Sugishila Y, Ilo I. The signal-averaged electrocardiogram as a screening tesl for occurrence of paroxysmal alrial fibrillalion. J Am Coll Cardiol 1988;! 1:116A.
52. Engel TR, Vallone N, Windle J. Signal-averaged eleclrocardiograms in patienls wilh atrial fibrillation or flutter. Am Heart J 1988:115:592-597.
53. Fukunami M, Yamada T, Ohmori M, el al. Delection of patients at risk for paroxysmal atrial fibrillalion during sinus rhylhm by P wave-triggered signal-averaged eleclrocardiogram. Circulation 1991:83:162-169.
54. Koudstaal PJ, van Gijn J, Klootwuk APJ, el al. Holler moniloring in patients with iransient and focal ischemie atlacks of ihe brain. Stroke 1986;17:192-195.
55. Britton M, de Faire U, Helmers C, et al. Arrhythmias in patients with acute cerebrovascular disease. Acta Med Scand 1979:205:425-428.
56. Richardt G, Ensle G, Schwarz F, el al. Diagnostik kardialer Ursachen zerebraler Embolien: Beitrag von 2D-Echokardiographie und Langzeil-EKG. Z Kard.iol 1989:78:598-601.
57. Morris JW, Froggall GM, Hachinski VC. Cardiac arrhylhmias in acute stroke. Stroke 1978:9:392-396.
58. Rem JA, Hachinski VC, Boughner DR, Barnett HJM. Value of cardiac moniloring and echocardiography in TIA and slroke patients. Slroke 1985;16:950-956.
59. Mikolich JR, Jacobs WC, Fletcher GF. Cardiac arrhylhmias in palients with acute cerebrovascular accidenls. JAMA 1981:246:1314-1317.
60. Hornig CR, Haberbosch W, Lammers C, el al. Specific cardiological evalualion after focal cerebral ischemia. Acta Neurol Scand 1996:93:297-302.
61. Lindgren A, Roijer A, Norrving B, el al. Carotid artery and heart disease in subtypes of cerebral infarclion. Slroke 1994;25:2356-2362.
62. Come PC, Riley MF, Bivas NK. Roles of echocardiography and arrhylhmia moniloring in ihe evalualion of patients with suspecled syslemic embolism. Ann Neurol 1983:13:527-531.
63. Tonel JL, Frank R, Ducardonnel A, et al. L'enregistrement de Holler dans les acidents ischemiques cerebraux. Nouv. Presse Med. 1981:10:2491-2494.
64. Kessler DK, Kessler KM. Is ambulatory electrocardiography useful in the evaluation of palienls wilh recent stroke? Chest 1995:107:916-918.
65. Bogousslavsky J, Hachinski VC, Boughner DR, et al. Cardiac and arterial lesions in carotid transienl ischemie attacks. Arch Neurol 1986;43:223-228.
66. Kessler DK, Kessler KM, Myerburg RJ. Ambulatory electrocardiography: a cost per management decision analysis. Arch Intern Med 1995;155:165-169.
67. Connoly SJ, Laupacis A, Gent M, et al. Canadian Atrial Fibrillation Anticoagulation (CAFA) study. J Am Coll Cardiol 1991;18:349-355.
68. The Atrial Fibrillation Investigators. The efficacy of aspirin in patients with atrial fibrillation: analysis of pooled data from 3 randomized trials. Arch Intern Med 1997;157:1237-1240.
69. Laupacis A. Re: CJ Green, DC Hadorn, K Bassett, A Kazanjian. Anticoagulation in chronic nonvalvular atrial fibrillation: a critical appraisal and meta-analysis. 1997;13:811-5.
70. Can J Cardiol. 1998; 14(5): 659,662-663.
71. Mant MJ. Re: CJ Green, DC Hadorn, K Bassett, A Kazanjian. Anticoagulation in chronic non-valvular atrial fibrillation: a critical appraisal and meta-analysis. 1997;13:811-815.
72. Can J Cardiol. 1998; 14(5): 663.
73. Levine MN, Hirsh J, Landefeld S, Raskob G. Hemorrhagic complications of anticoagulant treatment. Chest 1992;102 (suppl): 352S-363S.
74. The Stroke Prevention in Atrial Fibrillation Investigators. Bleeding during antithrombotic therapy in patients with atrial fibrillation. Arch Intern Med 1996; 156:409-416.
75. Albers GW. Atrial fibrillation and stroke: three new studies, three remaining questions. Arch Intern Med 1994;154:1443-1448.
76. The European Atrial Fibrillation Trial Study Group. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med 1995;333:5-IO.
77. Harrison DC, Fitzgerald JVV, Winkle RA. Ambulatory electrocardiography for diagnosis and treatment of cardiac arrhythmias. N Engl J Med 1976;294:373-380.
78. Hankey GJ, Warlow CP. Cost-effective investigation of patients with suspected transient ischaemic attacks. J Neurol Neurosurg Psychiatry. 1992;55:171-176.
79. Brown Jr RD, Evans BA, Wiebers DO, et al. Transient ischemie attack and minor ischémie stroke: an algorithm for evaluation and treatment. Mayo Clin Proc 1994;69:1027-1039.
80. Feinberg WM, Albers GW, Barnett HJM, et al. Guidelines for the management of transient ischemie attacks. Stroke 1994;25:1320-1335.